13F filerCIK 1061768 ↗

Baupost Group

You are looking at Q2 2021. See the latest, Q3 2026 →

Reported value

$12.33B

−1.9% on the quarter before

Positions

59

8 new, 8 sold out

Top 10

68.0%

of the value

Est. gain

+$514.0M

on stocks held all quarter

Est. return

+4.7%

on those stocks since Q1 2021

Filed

Aug 13, 2021

On SEC EDGAR ↗

Positions as of Jun 30, 2021, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2021. Striped tiles are options.

Liberty Global Plc12%
Intel9.9%
Ebay Inc.8.5%
Qorvo8.5%
35 others6.8%
Viasat Inc6.6%
Alphabet5.9%Micron4.9%Meta4.4%
Translate Bio Inc4.0%
Willis Towers Watson Plc Ltd3.5%
International Flavors&Fragra2.5%
Pg&E Corp2.5%
Nexstar Media Group Inc2.5%
Liberty Media Corp Del2.4%
Ss&C Technologies Hldgs Inc1.9%
Pershing Square Tontine Hldg1.9%
Veritiv Corp1.8%
Shaw Communications Inc1.8%
Liberty Global Plc1.7%
Digitalbridge Group Inc1.5%
Liberty Media Corp Del1.3%
Theravance Biopharma Inc1.2%
Verint Sys Inc1.1%
Atara Biotherapeutics Inc1.1%

Largest buys

Since Q1 2021, sized at quarter-end prices.

  1. Shaw Communications Inc~$218.1MNew, 0.0% → 1.8% of the portfolio+7,530,807 shares
  2. Digitalbridge Group Inc~$180.7MNew, 0.0% → 1.5% of the portfolio+22,877,059 shares
  3. Micron~$147.9MAdded, 3.8% → 4.9% of the portfolio+1,740,000 shares
  4. Meta~$86.9MAdded, 3.0% → 4.4% of the portfolio+250,000 shares
  5. Ironsource Ltd~$80.1MNew, 0.0% → 0.6% of the portfolio+8,000,000 shares
  6. Reinvent Technology Partners~$59.3MNew, 0.0% → 0.5% of the portfolio+6,000,000 shares
  7. Garrett Motion Inc~$28.5MNew, 0.0% → 0.2% of the portfolio+3,575,000 shares
  8. Qorvo~$21.5MAdded, 7.6% → 8.5% of the portfolio+110,000 shares
  9. Theravance Biopharma Inc~$17.1MAdded, 1.4% → 1.2% of the portfolio+1,175,000 shares
  10. The Beauty Health Company~$5.8MNew, 0.0% → 0.0% of the portfolio+898,981 shares

Largest sells

Since Q1 2021, sized at quarter-end prices.

  1. Fox Corp~$274.8MSold out, 2.2% → 0.0% of the portfolio−7,610,818 shares
  2. Ebay Inc.~$241.1MCut, 8.9% → 8.5% of the portfolio−3,433,800 shares
  3. Fox Corp~$198.4MSold out, 1.6% → 0.0% of the portfolio−5,680,307 shares
  4. Healthpeak Properties Inc~$157.7MSold out, 1.3% → 0.0% of the portfolio−4,966,911 shares
  5. Colony Cap Inc New~$156.9MSold out, 1.2% → 0.0% of the portfolio−24,212,959 shares
  6. Willis Towers Watson Plc Ltd~$140.0MCut, 4.6% → 3.5% of the portfolio−608,474 shares
  7. Fidelity National Financial~$123.5MSold out, 1.0% → 0.0% of the portfolio−3,036,935 shares
  8. Intel~$87.6MCut, 11.9% → 9.9% of the portfolio−1,560,384 shares
  9. Reinvent Technology Partners~$60.2MSold out, 0.5% → 0.0% of the portfolio−6,000,000 shares
  10. Pershing Square Tontine Hldg~$59.6MCut, 2.4% → 1.9% of the portfolio−2,617,269 shares

Holdings

As of Jun 30, 2021; changes in shares since Mar 31, 2021.

Positions, sorted by share of the portfolio
HoldingValue
Liberty Global PlcSHS CL C · shares −1.1% · price +5.9%11.8%$1.46B+$81.0M
IntelCOM · shares −6.7% · price −12.3%9.9%$1.22B−$170.9M
Ebay Inc.COM · shares −19% · price +14.6%8.5%$1.05B+$133.6M
QorvoCOM · shares +2.1% · price +7.1%8.5%$1.04B+$67.7M
Viasat IncCOM · shares 0% · price +3.7%6.6%$811.8M+$28.8M
AlphabetCAP STK CL C · shares 0% · price +21.2%5.9%$729.2M+$127.3M
MicronCOM · shares +32% · price −3.7%4.9%$608.7M−$17.5M
MetaCL A · shares +19% · price +18.1%4.4%$537.9M+$69.0M
Translate Bio IncCOM · shares 0% · price +66.8%4.0%$493.5M+$197.7M
Willis Towers Watson Plc LtdSHS · shares −24% · price +0.5%3.5%$435.1M+$2.2M
International Flavors&FragraCOM · shares 0% · price +7.0%2.5%$313.7M+$20.6M
Pg&E CorpCOM · shares 0% · price −13.2%2.5%$311.8M−$47.2M
Nexstar Media Group IncCL A · shares −1.9% · price +5.3%2.5%$302.6M+$15.2M
Liberty Media Corp DelCOM C SIRIUSXM · shares 0% · price +5.2%2.4%$300.8M+$14.8M
Ss&C Technologies Hldgs IncCOM · shares −13% · price +3.1%1.9%$239.0M+$7.3M
Pershing Square Tontine HldgCOM CL A · shares −21% · price −5.2%1.9%$229.7M−$12.6M
Veritiv CorpCOM · shares 0% · price +44.4%1.8%$218.9M+$67.3M
Shaw Communications IncCL B CONV · shares New1.8%$218.1M—
Liberty Global PlcSHS CL A · shares 0% · price +5.8%1.7%$208.0M+$11.5M
Digitalbridge Group IncCL A COM · shares New1.5%$180.7M—
Liberty Media Corp DelCOM A SIRIUSXM · shares 0% · price +5.7%1.3%$163.0M+$8.8M
Theravance Biopharma IncCOM · shares +13% · price −28.9%1.2%$143.9M−$51.5M
Verint Sys IncCOM · shares 0% · price −0.9%1.1%$137.0M−$1.3M
Atara Biotherapeutics IncCOM · shares 0% · price +8.3%1.1%$131.8M+$10.1M
Advantage Solutions IncCOM CL A · shares −2.4% · price −7.5%1.1%$129.6M−$10.5M
Total 59 positions100%$12.33B+$514.0M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q1 2021 to Q2 2021: 50 stocks held throughout, up $514.0M (+4.7%).

  1. Translate Bio Inc+$197.7M+67%
  2. Ebay Inc.+$133.6M+15%
  3. Alphabet+$127.3M+21%
  4. Liberty Global Plc+$81.0M+6%
  5. Meta+$69.0M+18%
  6. Micron−$17.5M−4%
  7. Cullinan Oncology Inc−$25.4M−35%
  8. Pg&E Corp−$47.2M−13%
  9. Theravance Biopharma Inc−$51.5M−29%
  10. Intel−$170.9M−12%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$20.00B$10.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$5.05B−7%SEC ↗
Q2 2026$5.42B+6%SEC ↗
Q1 2026$5.12B−3%SEC ↗
Q4 2025$5.28B+10%SEC ↗
Q3 2025$4.79B+16%SEC ↗
Q2 2025$4.13B+18%SEC ↗
Q1 2025$3.50B+2%SEC ↗
Q4 2024$3.43B−2%SEC ↗
Q3 2024$3.52B−3%SEC ↗
Q2 2024$3.63B−0%SEC ↗
Q1 2024$3.65B−20%SEC ↗
Q4 2023$4.59B−12%SEC ↗
Q3 2023$5.21B−7%SEC ↗
Q2 2023$5.61B−4%SEC ↗
Q1 2023$5.85B−5%SEC ↗
Q4 2022$6.13B+6%SEC ↗
Q3 2022$5.79B−14%SEC ↗
Q2 2022$6.77B−27%SEC ↗
Q1 2022$9.30B−8%SEC ↗
Q4 2021$10.13B−7%SEC ↗
Q3 2021$10.88B−12%SEC ↗
Q2 2021$12.33B−2%SEC ↗
Q1 2021$12.56B+16%SEC ↗
Q4 2020$10.84B+17%SEC ↗
Q3 2020$9.25B+15%SEC ↗
Q2 2020$8.01B+18%SEC ↗
Q1 2020$6.77B−25%SEC ↗
Q4 2019$9.06B+3%SEC ↗
Q3 2019$8.83B−20%SEC ↗
Q2 2019$11.05B−7%SEC ↗
Q1 2019$11.90B+3%SEC ↗
Q4 2018$11.52B−12%SEC ↗
Q3 2018$13.06B+14%SEC ↗
Q2 2018$11.44B+10%SEC ↗
Q1 2018$10.37B+3%SEC ↗
Q4 2017$10.11B+26%SEC ↗
Q3 2017$8.02B−8%SEC ↗
Q2 2017$8.75B+3%SEC ↗
Q1 2017$8.49B+11%SEC ↗
Q4 2016$7.67B+9%SEC ↗
Q3 2016$7.04B−4%SEC ↗
Q2 2016$7.37B+6%SEC ↗
Q1 2016$6.92BSEC ↗

Subscribe to TheInference for free